5`-Guanosine diphosphate-fucose disodium salt—the core of glycobiology development 15839-70-0
Guanosine5′-diphospho-β-L-fucose is a key member of the sugar nucleotide family. As the core substrate of cellular glycosylation reactions, it occupies an indispensable position in the fields of glycobiology, synthetic biology and biomedicine. It is not only a high-energy intermediate that drives the construction of sugar chains in natural metabolic pathways, but also a basic tool in the development of modern sugar engineering and innovative therapies, providing a molecular cornerstone for exploring the sugar code in life processes.
Guanosine5′-diphospho-β-L-fucose is a key member of the sugar nucleotide family. As the core substrate of cellular glycosylation reactions, it occupies an indispensable position in the fields of glycobiology, synthetic biology and biomedicine. It is not only a high-energy intermediate that drives the construction of sugar chains in natural metabolic pathways, but also a basic tool in the development of modern sugar engineering and innovative therapies, providing a molecular cornerstone for exploring the sugar code in life processes.
Chemical Information
Chemical name: 5`-Guanosine diphosphate-fucose disodium salt
Common name: Guanosine 5′-diphospho-β-L-fucose
Chemical formula: C16H25N5O15P2
Molecular weight: 589.34 g/mol
CAS number: 15839-70-0
Category: Sugar Nucleotides
Structural features
The structure of 5`-guanosine diphosphate-fucose disodium salt demonstrates the unique design of sugar nucleotides. Its features include:
High-energy glycosyl donor structure: The molecule is composed of guanine nucleoside connected to the diphosphate group through the 5'-position, and then combined with β-L-fucose through a glycosidic bond. This structure allows the diphosphate bond to store higher chemical potential energy and efficiently drive enzymatic glycosylation reactions. At the same time, the sodium salt form improves water solubility and stability, making it easier to handle experimental treatments.
Stereochemical accuracy: The specific configuration of β-L-fucose ensures its high specificity in biological recognition, allowing the compound to be accurately recognized by glycosyltransferases, thereby guiding the precise addition of fucose units to target molecules such as proteins or lipids.
Dual-functional modularity: The structure combines the energy transfer properties of nucleotides and the recognition function of sugars, making it a bridge connecting nucleic acid metabolism and sugar chain synthesis, playing the dual role of metabolic signal and synthetic substrate in cells.
Main applications and advantages
Core tools for glycosylation mechanism research and enzymatic synthesis
Driving biosynthetic pathways: In organisms, sugar nucleotides such as 5`-guanosine diphosphate-fucose disodium salt are exclusive substrates for glycosyltransferases, which are used to catalyze the transfer of fucose to glycoproteins, glycolipids or oligosaccharide chains. This process regulates key biological events such as cell adhesion, immune response, and signal transduction. Studying this compound will help analyze the spatiotemporal dynamics and functions of glycosylation.
Enables in vitro glycoengineering: In synthetic biology, this compound provides a reliable raw material for the enzymatic synthesis of homogenized sugar structures. By combining glycosyltransferase systems, it can be used to construct complex sugar chains or modify biological macromolecules, promote the development of sugar vaccines, glycoprotein drugs and cell surface engineering, and improve the targeting and stability of therapeutic molecules.
Disease model construction and targeted therapy exploration
Mimics pathological glycosylation: Many diseases such as cancer, chronic inflammation, and inherited metabolic disorders are closely related to abnormal fucosylation. 5`-Guanosine diphosphate-fucose disodium salt is used as a research substrate, allowing the simulation of disease-related glycosylation changes at the cellular or enzyme level, helping to reveal the regulatory mechanism of the sugar code in pathological conditions.
Development of potential therapeutic strategies: Intervention of the fucosylation pathway has become a new direction in drug development. This compound can be used as a tool for screening glycosyltransferase inhibitors or activators, providing a molecular basis for developing strategies to regulate immune checkpoints, inhibit tumor metastasis or treat infectious diseases.
Basic science and diagnostic technology development
Analysis of cell surface glycocalyx: Fucose is an important component of cell surface glycocalyx and participates in processes such as microbial recognition and inflammatory response. Using 5′-guanosine diphosphate-fucose disodium salt, sugar chains can be labeled or modified to visualize glycocalyx dynamics and deepen our understanding of cell communication and host-pathogen interactions.
Biomarker discovery platform: In some diseases, changes in specific fucosylation patterns can be used as early diagnostic indicators. The compound supports the development of glycomics-based detection methods, such as quantification of glycosylation levels through enzyme-linked assays or mass spectrometry techniques, driving the advancement of non-invasive diagnostic tools such as liquid biopsies.
Conclusion
Far from being just a metabolic intermediate, 5`-guanosine diphosphate-fucose disodium salt is a key reagent in decoding the complexity of glycobiology. From basic mechanism insights to cutting-edge therapeutic design, its extensive application in glycoscience, immune engineering and synthetic biology manufacturing is accelerating the birth of a new generation of glycosylated drugs. As the era of precision medicine and sugar drugs advances, this sugar nucleotide will continue to inject core power into breakthroughs in the field of human health.
The above information is provided by the editor of KASONS and is for scientific research only.
